Company / Free Cash Flow per Share
Decoy Therapeutics Inc. Free Cash Flow per Share History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.43
FY2021
5-year range
-$2.57 / -$0.43
FY2017-FY2021
Trend
+83.1%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share returned to growth in FY2021 after 3 years of decline, reaching $-0.43.
Based on SEC 10-K filings.
-0.43 in FY2021.
Improved from $-1.83 to $-0.43 over the past 3 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, free cash flow per share increased 83.1% year-over-year.
- Peak free cash flow per share was recorded in FY2016.
- Lowest free cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | - | - |
| FY2021 | -$0.43 | +83.1% |
| FY2020 | -$2.57 | - |
| FY2019 | - | - |
| FY2018 | -$1.83 | -46.3% |
| FY2017 | -$1.25 | -200.7% |
| FY2016 | -$0.42 | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026